Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
about
A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy.Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine TumorsSafety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphomaNonfunctional neuroendocrine tumor of the pancreas: Case report and review of the literature.Everolimus in the treatment of patients with advanced pancreatic neuroendocrine tumors: latest findings and interpretations.
P2860
Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
@ast
Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
@en
type
label
Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
@ast
Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
@en
prefLabel
Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
@ast
Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
@en
P2860
P356
P1476
Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
@en
P2093
M Wasif Saif
Paul E Oberstein
P2860
P356
10.4137/CMO.S7319
P407
P577
2012-01-04T00:00:00Z